Apogee Therapeutics, Inc. - Common Stock, $0.00001 par value per share (APGE)

Historical Holders from Q3 2023 to Q1 2025

Symbol
APGE on Nasdaq
CUSIP
03770N101
Type / Class
Equity / Common Stock, $0.00001 par value per share
Shares outstanding
45.2M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
57.9M
Holdings value
$2.62B
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
156
Number of buys
83
Number of sells
-60
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Apogee Therapeutics, Inc. - Common Stock, $0.00001 par value per share (APGE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RTW INVESTMENTS, LP 6% $101M 2.71M RTW Investments, LP Dec 31, 2024

Institutional Holders of Apogee Therapeutics, Inc. - Common Stock, $0.00001 par value per share (APGE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 62.7K $2.34M -$361K $37.36 7
2024 Q4 57.9M $2.62B +$63.4M $45.30 156
2024 Q3 56.1M $3.29B +$134M $58.74 139
2024 Q2 54.2M $2.13B -$9.27M $39.35 137
2024 Q1 52.9M $3.52B +$773M $66.45 138
2023 Q4 41.8M $1.16B +$47.2M $27.94 85
2023 Q3 40.1M $849M +$849M $21.30 72